Adverse Drug Reaction Classification System

ADR Ontology
ADR Term HIV infection
ADR ID BADD_A02082
ADR Hierarchy
10      Immune system disorders
10.03      Immunodeficiency syndromes
10.03.03      Acquired immunodeficiency syndromes
10.03.03.002      HIV infection
11      Infections and infestations
11.05      Viral infectious disorders
11.05.17      Retroviral infections
11.05.17.002      HIV infection
Description Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). [MeSH]
MedDRA Code 10020161
MeSH ID D015658; D015497
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Chronic HIV infection | Chronic infection with HIV | HIV disease | HIV infection | HIV infection NOS | HIV-1 | Human immunodeficiency virus infection causing lymphadenopathy | Human immunodeficiency virus infection causing other disorders involving the immune mechanism | Human immunodeficiency virus infection causing other specified conditions | Human immunodeficiency virus infection causing other specified infections | Human immunodeficiency virus infection causing specified acute infections | Human immunodeficiency virus infection causing specified disease of the central nervous system | Human immunodeficiency virus infection with specified conditions | Human immunodeficiency virus infection with specified infections | Human immunodeficiency virus infection with specified malignant neoplasms | Human immunodeficiency virus infection, unspecified | Human immunodeficiency virus syndrome | Human immunodeficiency virus type | Human immunodeficiency virus type I infection with specific secondary infections | Human immunodeficiency virus, type 2 infection in conditions classified elsewhere and of unspec sit | Human immunodeficiency virus, type 2 infection in conditions classified elsewhere and of unspec site | Human T-cell leukaemia virus III | Human T-cell lymphotrophic virus, type II infection in cond class elsewhere and of unspec site | Human T-cell lymphotropic virus type III infection | Other human immunodeficiency virus infection | HIV disease progression | Human T-cell leukemia virus III | HIV-1 infection | HIV infection CDC category unspecified | HIV coinfection | HIV Infections | HIV Infection | Infection, HIV | Infections, HIV | HTLV-III-LAV Infections | HTLV III LAV Infections | HTLV-III-LAV Infection | Infection, HTLV-III-LAV | Infections, HTLV-III-LAV | T-Lymphotropic Virus Type III Infections, Human | T Lymphotropic Virus Type III Infections, Human | HTLV-III Infections | HTLV III Infections | HTLV-III Infection | Infection, HTLV-III | Infections, HTLV-III | HIV Coinfection | Coinfection, HIV | Coinfections, HIV | HIV Coinfections
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01953Rituximab--
The 1th Page    1    Total 1 Pages